Gastrointestinal involvement in STEC-associated hemolytic uremic syndrome: 10 years in a pediatric center

Mario Giordano1, Onofrio Iacoviello2, Luisa Santangelo3

  • 1Pediatric Nephrology and Dialysis Unit, Pediatric Hospital Giovanni XXIII - AOU Consorziale Policlinico, Bari, Italy. mariogiordanobari@fastwebnet.it.

Insights

Gastrointestinal complications, including severe bowel issues, are common in Shiga toxin-producing E. coli hemolytic uremic syndrome (STEC-HUS) in children. Hepatopancreatic involvement is frequent but typically resolves without specific E. coli or Shiga toxin correlations.

Area of Science:

  • Pediatric Nephrology
  • Gastroenterology
  • Infectious Diseases

Background:

  • The gastrointestinal tract is a primary target in pediatric Shiga toxin-producing Escherichia coli hemolytic uremic syndrome (STEC-HUS).
  • Understanding the spectrum of GI complications and hepatopancreatic involvement is crucial for managing STEC-HUS.

Purpose of the Study:

  • To characterize gastrointestinal complications in children with STEC-HUS.
  • To investigate the association between specific E. coli serotypes/Shiga toxin variants and hepatopancreatic involvement.

Main Methods:

  • Observational study of 79 pediatric STEC-HUS patients from January 2012 to June 2021.
  • Detailed recording of demographic, clinical, laboratory, intestinal, hepatobiliary, and pancreatic data.
  • Analysis of gastrointestinal complication frequency based on E. coli serotypes and Stx variants.

Main Results:

  • Six patients experienced bowel complications, including rectal prolapse and life-threatening bowel perforation (3/6 deaths).
  • Acute pancreatitis occurred in 13 patients; elevated pancreatic enzymes and liver transaminases were common.
  • Hepatopancreatic involvement showed no correlation with specific E. coli serotypes or Shiga toxin variants.

Conclusions:

  • Gastrointestinal complications in STEC-HUS range from mild laboratory abnormalities to severe, fatal events like bowel perforation.
  • Hepatopancreatic involvement is a frequent finding in STEC-HUS, generally presenting as a self-limiting condition.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...